(Q42647738)

4 November 2017

Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children (English)

1 reference

4 November 2017

1 reference

1 reference

Oo C

1

1 reference

4 November 2017

Barrett J

2

1 reference

4 November 2017

Hill G

3

1 reference

4 November 2017

Mann J

4

1 reference

4 November 2017

Dorr A

5

1 reference

4 November 2017

Dutkowski R

6

1 reference

4 November 2017

Ward P

7

1 reference

4 November 2017

1 January 2001

1 reference

4 November 2017

1 reference

4 November 2017

3

1 reference

4 November 2017

229-236

1 reference

4 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00128072-200103030-00005

4 November 2017

0 references

cites work

Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine.

1 reference

12 December 2020

Population pharmacokinetics of carboplatin in children

1 reference

12 December 2020

Prevention and treatment of influenza

1 reference

12 December 2020

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

12 December 2020

Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers

1 reference

12 December 2020

Influenza and hospitalizations in children

1 reference

12 December 2020

Population pharmacokinetics of vancomycin in Japanese pediatric patients.

1 reference

12 December 2020

Developmental patterns of renal functional maturation compared in the human neonate

1 reference

12 December 2020

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

1 reference

12 December 2020

Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.

1 reference

12 December 2020

Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza

1 reference

12 December 2020

Is pediatric labeling really necessary?

1 reference

12 December 2020

Children with influenza A infection: treatment with rimantadine.

1 reference

12 December 2020

The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796/GS4104) in healthy adult and elderly volunteers.

1 reference

12 December 2020

The impact of influenza epidemics on hospitalizations.

1 reference

12 December 2020

Developmental changes in hepatic esterase activity towards chloramphenicol succinate and its Michaelis-Menten constant of liver, kidney and lung in human.

1 reference

12 December 2020

Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802.

1 reference

12 December 2020

10.2165/00128072-200103030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

4 November 2017

0 references

1 reference